These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2523663)

  • 21. An acute dose-response pharmacodynamic evaluation of orally administered isradipine (PN-200-110) in hypertensive patients.
    McMahon FG; Vargas R; Ryan JR; Miller H; Faraday S
    J Clin Pharmacol; 1988 Jul; 28(7):664-6. PubMed ID: 2975291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose isradipine once daily effectively controls 24-h blood pressure in essential hypertension.
    Diemont WL; Stegeman CJ; Beekman J; Siegers AM; Hagels G; de Bruijn JH
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):163S-167S. PubMed ID: 1827011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isradipine twice daily lowers blood pressure over 24 H.
    Man in't Veld AJ; Holmes DG; Lasance A; de Zwart P
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):131S-134S. PubMed ID: 1827003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
    Kirch W; Burger KJ; Weidinger G; Welzel D
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients.
    Holtzman JL; Abrams A; Cutler R; Hamilton B; Kirkendall WM; Neri G; Stein GH; Matthews KP
    Clin Pharmacol Ther; 1990 Nov; 48(5):590-7. PubMed ID: 2146060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of calcium antagonists to treat intra-operative hypertension--evaluation of efficacy and safety of a new dihydropyridine derivative, intravenous isradipine, during abdominal surgery.
    Edouard A; Dartayet B; Ruegg C; Samii K
    Eur J Anaesthesiol; 1991 Sep; 8(5):351-8. PubMed ID: 1834462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time course of the blood pressure response to oral isradipine in uncomplicated mild-to-moderate essential hypertension.
    Leary WP; Reyes AJ; Maharaj B; van der Byl K
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):147S-150S. PubMed ID: 1827006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First clinical experience with isradipine in the treatment of hypertension in Portugal.
    Rocha-Gonçalves F; Mariano-Pego G; Viegas J; Correia JM; Botelho MA
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S4-6. PubMed ID: 1720485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of isradipine and atenolol on peripheral hemodynamics and arterial compliance.
    Jespersen LT; Krusell LR; Sihm I; Pedersen OL
    Am J Med; 1989 Apr; 86(4A):57-9. PubMed ID: 2523656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of the international literature on isradipine in hypertension (Lomir/Dynacirc).
    Soland FX
    Cor Vasa; 1990; 32(2 Suppl 1):61-72. PubMed ID: 2143461
    [No Abstract]   [Full Text] [Related]  

  • 31. Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol.
    Cantor A; Cristal N
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S76-8. PubMed ID: 1695309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The calcium antagonist isradipine in the therapy of hypertension. A double-blind crossover comparison with nifedipine.
    Welzel D; Burger KJ
    Drugs; 1990; 40 Suppl 2():60-4. PubMed ID: 2150644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter comparison of the safety and efficacy of isradipine and enalapril in the treatment of hypertension.
    Eisner GM; Johnson BF; McMahon FG; Rudd P; Sowers JR; Vargas R; Zemel M
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):154S-157S. PubMed ID: 1827008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
    Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L
    Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Isradipine, a calcium antagonist in hypertension].
    Christensen HR; Graudal N
    Ugeskr Laeger; 1990 Aug; 152(34):2448-50. PubMed ID: 2144928
    [No Abstract]   [Full Text] [Related]  

  • 36. Isradipine dose-confirmation study in Filipino patients with mild to moderate hypertension.
    Abarquez RF; Cabral EI; Namin EP; Calleja HB; Porciuncula CI; Divinagracia RA; Anastacio RV; Castillo RR
    Drugs; 1990; 40 Suppl 2():33-7. PubMed ID: 2150639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
    Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
    Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term renal effects of isradipine, a calcium entry blocker, in essential hypertension.
    Persson B; Wysocki M; Andersson OK
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):22-4. PubMed ID: 2475710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long-term effect of isradipine in pindolol-treated patients.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
    J Hypertens Suppl; 1987 Dec; 5(5):S567-70. PubMed ID: 2965231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
    Fitscha P; Meisner W; Hitzenberger G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.